
As AI becomes increasingly commoditized, Initiate Ventures' Jessica Owens argues healthcare and life sciences companies need to use it to solve historically intractable problems, not just streamline workflows. On The BioCentury Show, Owens breaks down how she evaluates founders, when Initiate chooses to fund versus co-found a company, and why she believes proprietary data now matters more than any proprietary model. Owens also discusses gaps in evidence generation for diagnostics, and closes ...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Ep. 119 - Blackstone's Galakatos on funding biotech's hardest mile

Ep. 118 - Regeneron's Gonçalo Abecasis on turning genetic data into drug targets

Ep. 117 - C-Path's Klaus Romero on moving genetic medicines beyond one patient

Ep. 116 - Ovid's Jeremy Levin on biotech in the balance
Free AI-powered recaps of The BioCentury Show and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.